Latest Production News

Lark Distilling Co. Ltd reported a 7% increase in net sales revenue for Q2FY25, driven by strong growth in direct-to-consumer, global travel retail, and export channels despite domestic B2B challenges. The company is advancing its brand restage and maintaining solid cash reserves.

Biome Australia Limited has announced encouraging results from functional studies on its probiotic strain BMB18, highlighting its potential to modulate immune responses, reduce inflammation, and support intestinal health. These findings pave the way for targeted clinical research and product innovation.

Articore Group reveals a strategic restructure delivering significant cost savings and improved margins, even as marketplace revenue continues to decline. The launch of a new product, Dashery, aims to diversify revenue streams.

Change Financial Limited reported a robust Q2 FY25 with revenue surging 53% year-on-year, driven by its expanding PaaS platform, while strategically exiting its loss-making US operations to sharpen focus on Australia and New Zealand.

Doctor Care Anywhere delivered positive cash flow and revenue growth at the top of guidance in Q4 2024, while navigating a strategic shift with new leadership appointments and the closure of secondary care pathways.

NGX Limited reports significant progress in its uranium exploration in Namibia and graphite development in Malawi, alongside strategic leadership changes and a strong financial position.

MedAdvisor Limited reported a significant 38.6% drop in 2Q FY25 revenue due to vaccine program deferrals but expects a stronger second half driven by a diversified US pipeline and cost-saving initiatives.

Alcidion Group Limited reported robust Q2 FY25 sales of $13.1 million and improved cash flow, reinforcing its forecast to achieve EBITDA and cashflow positivity by the end of FY25.

Wisr has reported a robust Q2FY25 with loan originations surging 77% year-on-year to $93.5 million, alongside improving credit metrics and a well-capitalised balance sheet.

Zimplats' December quarter report reveals a decline in mined and milled volumes alongside increased cash costs per 6E ounce, even as key expansion projects advance steadily.

Audeara Ltd reports a 70% jump in Q2 FY25 cash receipts, driven by new product launches and a major contract with Avedis Zildjian. The company’s expansion into Taiwan and international markets signals a promising growth trajectory.

Clever Culture Systems Ltd has achieved a key cashflow break-even milestone in Q4 2024, driven by strong sales growth from major pharmaceutical clients including AstraZeneca and Bristol Myers Squibb. The company is also advancing its product line with a new APAS® Contact Plate capability set for mid-2025 launch.